HPM
UTHR icon

Hudson Portfolio Management’s United Therapeutics UTHR Stock Holding History

Hudson Portfolio Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$740K Sell
1,365
-430
-24% -$242K 0.56% 54
2026
Q1 		$1.06M Sell
1,795
-315
-15% -$157K 0.9% 40
2025
Q4 		$1.03M Sell
2,110
-80
-4% -$37.3K 0.89% 38
2025
Q3 		$918K Sell
2,190
-20
-0.9% -$6.73K 0.81% 40
2025
Q2 		$635K Sell
2,210
-35
-2% -$10.5K 0.59% 55
2025
Q1 		$692K Sell
2,245
-28
-1% -$9.6K 0.66% 51
2024
Q4 		$802K Sell
2,273
-262
-10% -$96.3K 0.79% 43
2024
Q3 		$908K Buy
+2,535
New +$856K 0.89% 36
2023
Q4 		$557K Sell
2,535
-83
-3% -$19.1K 0.6% 55
2023
Q3 		$591K Sell
2,618
-860
-25% -$198K 0.67% 48
2023
Q2 		$768K Hold
3,478
– – 0.83% 43
2023
Q1 		$779K Sell
3,478
-45
-1% -$11.1K 0.87% 43
2022
Q4 		$980K Hold
3,523
– – 1.08% 35
2022
Q3 		$737K Hold
3,523
– – 0.87% 43
2022
Q2 		$830K Sell
3,523
-35
-1% -$7.12K 0.86% 44
2022
Q1 		$638K Sell
3,558
-22
-0.6% -$4.19K 0.56% 57
2021
Q4 		$773K Hold
3,580
– – 0.68% 51
2021
Q3 		$660K Hold
3,580
– – 0.61% 58
2021
Q2 		$642K Sell
3,580
-60
-2% -$11.4K 0.59% 59
2021
Q1 		$608K Buy
+3,640
New +$607K 0.59% 58

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Hudson Portfolio Management's UTHR Position: Q2 2026 in Review

Hudson Portfolio Management reduced its United Therapeutics (UTHR) stake by 24% in Q2 2026, selling an estimated $242K and leaving 1,365 shares worth $740K. The position accounts for 0.56% of the portfolio, ranked #54.

Hudson Portfolio Management first reported a position in UTHR in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.06M in Q1 2026. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Hudson Portfolio Management held 1,365 shares of United Therapeutics worth $740K as of Q2 2026.
  • Hudson Portfolio Management sold 430 United Therapeutics shares in Q2 2026, an estimated $242K.
  • United Therapeutics made up 0.56% of Hudson Portfolio Management's portfolio in Q2 2026, its #54 holding.
  • Hudson Portfolio Management first reported a position in United Therapeutics in Q1 2021 and has held it in 20 quarters since.
  • Hudson Portfolio Management's United Therapeutics position peaked at $1.06M in Q1 2026.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Hudson Portfolio Management's 13F filing for Q2 2026, filed 12 Aug 2026.